Inspection tour part of the MoHAP’s strategy aimed at implementing national standards

Dubai, UAE, 21st December 2019: GlobalPharma, a wholly-owned subsidiary of Dubai Investments PJSC,  hosted His Excellency Dr Amin Hussain Al Amiri, Assistant Undersecretary for Medical Practice and Licence Sector in the UAE Ministry of Health and Chairman of the UAE Supreme National Blood Transfusion Committee, and his accompanying delegation, Dr Ruqaya Al Bastaki, Director of Drug Department, Ministry of Health and Prevention (MoHAP); and Dr Rita Al Shalouhi, Expert in Pharmaceutical Policies; to the facility located at Dubai Investment Park (DIP).

Abdulaziz Bin Yagub Al Serkal, CEO of Industrial Platform - Dubai Investments PJSC; along with Dr Bassem Albarameh, Acting General Manager of Globalpharma; Dr Idrees Siddiqui, Director of the Globalpharma Site; and Mohamed Alloush, Director of Regulatory Affairs and Registration; welcomed the officials to the Globalpharma facility.

The inspection tour, part of MoHAP’s strategy, aimed at implementing national standards, strengthening, monitoring, and supervising the role of medical and pharmaceutical institutions, and reinforcing the role of inspection by increasing the number of judicial inspectors across the country.

As part of the inspection visit, HE Dr Amin discussed the company's future plans for the advancement of the pharmaceutical industry in the country and ways and areas of cooperation with the Ministry of Health to promote and develop ambitious plans in line with UAE Vision 2030.

His Excellency added: “The local government is proud of the homeland and the citizen. It is time that an Emirati citizen, with his experience and efficiency, finds the right place in this important sector to achieve prosperity and development.”

The flexibility of the MoHAP’s inspection teams dealing with the health facilities and local production facilities, as well as their continuous communication with them, helps increase the adherence to laws and enhance the spirit of responsibility and self-censorship among manufacturers and healthcare facilities. 

MoHAP stressed on the importance of exports, encouraging local factories to enhance exporting to other countries so that the UAE drug is available across all countries of the region, enhancing the national economy.

-ENDS-